More about OXON
The Oxford Antibiotic Group is an innovative drug discovery and development company that brings together Austrian drug development expertise with Oxford’s excellence in Chemistry and Life Sciences.
Our mission is to find a solution for the unmet medical need in bacterial resistance, and to save life with new antibacterial therapies. Oxford Antibiotic works with Equinox International on exclusive cannabis whole plant formulations.
Please visit https://oxfordantibioticgroup.com/ for more information.